<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35407562</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>31</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Detection of Male Hypogonadism in Patients with Post COVID-19 Condition.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1955</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11071955</ELocationID><Abstract><AbstractText>The pathogenesis and prognosis of post COVID-19 condition have remained unclear. We set up an outpatient clinic specializing in long COVID in February 2021 and we have been investigating post COVID-19 condition. Based on the results of our earlier study showing that &#x201c;general fatigue&#x201d; mimicking myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is the most common symptom in long COVID patients, a retrospective analysis was performed for 39 male patients in whom serum free testosterone (FT) levels were measured out of 61 male patients who visited our clinic. We analyzed the medical records of the patients&#x2019; backgrounds, symptoms and laboratory results. Among the 39 patients, 19 patients (48.7%) met the criteria for late-onset hypogonadism (LOH; FT &lt; 8.5 pg/mL: LOH group) and 14 patients were under 50 years of age. A weak negative correlation was found between age and serum FT level (r = &#x2212;0.301, p = 0.0624). Symptoms including general fatigue, anxiety, cough and hair loss were more frequent in the LOH group than in the non-LOH group (FT &#x2265; 8.5 pg/mL). Among various laboratory parameters, blood hemoglobin level was slightly, but significantly, lower in the LOH group. Serum level of FT was positively correlated with the levels of blood hemoglobin and serum total protein and albumin in the total population, whereas these interrelationships were blurred in the LOH group. Collectively, the results indicate that the incidence of LOH is relatively high in male patients, even young male patients, with post COVID-19 and that serum FT measurement is useful for revealing occult LOH status in patients with long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Yukichika</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6015-6128</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunada</LastName><ForeName>Naruhiko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokumasu</LastName><ForeName>Kazuki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9972-791X</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakurada</LastName><ForeName>Yasue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiya</LastName><ForeName>Hideharu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5086-1891</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanayama</LastName><ForeName>Yoshihisa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Fumio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7014-9095</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LOH syndrome</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">hypogonadism</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">testosterone</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35407562</ArticleId><ArticleId IdType="pmc">PMC8999458</ArticleId><ArticleId IdType="doi">10.3390/jcm11071955</ArticleId><ArticleId IdType="pii">jcm11071955</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nuzzo J.B., Gostin L.O. The First 2 Years of COVID-19: Lessons to Improve Preparedness for the Next Pandemic. JAMA. 2022;327:217&#x2013;218. doi: 10.1001/jama.2021.24394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.24394</ArticleId><ArticleId IdType="pubmed">34989763</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms among Patients with COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka Y., Nakano Y., Hagiya H., Tokumasu K., Otsuka F. Recovery from Alopecia after COVID-19. Cureus. 2022;14:e21160. doi: 10.7759/cureus.21160.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.21160</ArticleId><ArticleId IdType="pmc">PMC8831424</ArticleId><ArticleId IdType="pubmed">35165610</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv. 2021 doi: 10.1101/2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka Y., Tokumasu K., Nakano Y., Honda H., Sakurada Y., Sunada N., Omura D., Hasegawa K., Hagiya H., Obika M., et al. Clinical Characteristics of Japanese Patients Who Visited a COVID-19 Aftercare Clinic for Post-Acute Sequelae of COVID-19/Long COVID. Cureus. 2021;13:e18568. doi: 10.7759/cureus.18568.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18568</ArticleId><ArticleId IdType="pmc">PMC8571943</ArticleId><ArticleId IdType="pubmed">34760415</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurada Y., Sunada N., Honda H., Tokumasu K., Otsuka Y., Nakano Y., Hanayama Y., Furukawa M., Hagiya H., Otsuka F. Serial Changes of Long COVID Symptoms and Clinical Utility of Serum Antibody Titers for Evaluation of Long COVID. J. Clin. Med. 2022;11:1309. doi: 10.3390/jcm11051309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11051309</ArticleId><ArticleId IdType="pmc">PMC8911256</ArticleId><ArticleId IdType="pubmed">35268400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Crispo A., Bimonte S., Porciello G., Forte C.A., Cuomo G., Montagnese C., Prete M., Grimaldi M., Celentano E., Amore A., et al. Strategies to evaluate outcomes in long-COVID-19 and post-COVID survivors. Infect. Agents Cancer. 2021;16:62. doi: 10.1186/s13027-021-00401-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-021-00401-3</ArticleId><ArticleId IdType="pmc">PMC8556851</ArticleId><ArticleId IdType="pubmed">34717691</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B., Head R., Pringle K.G., Lumbers E.R., Martin J.H. &#x201c;LONG COVID&#x201d;&#x2014;A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol. Res. Perspect. 2022;10:e00911. doi: 10.1002/prp2.911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R., Gubbi S., Koch C.A. COVID-19 and chronic fatigue syndrome: An endocrine perspective. J. Clin. Transl. Endocrinol. 2022;27:100284. doi: 10.1016/j.jcte.2021.100284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcte.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G., Goulis D.G., Huhtaniemi I., Zitzmann M., Toppari J., Forti G., Vanderschueren D., Wu F.C. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology. Andrology. 2020;8:970&#x2013;987. doi: 10.1111/andr.12770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12770</ArticleId><ArticleId IdType="pubmed">32026626</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A., Bettocchi C., Boeri L., Capogrosso P., Carvalho J., Cilesiz N.C., Cocci A., Corona G., Dimitropoulos K., Gul M., et al. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction. Eur. Urol. 2021;80:333&#x2013;357. doi: 10.1016/j.eururo.2021.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2021.06.007</ArticleId><ArticleId IdType="pubmed">34183196</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamoto T., Yanase T., Horie H., Namiki M., Okuyama A. Late-onset hypogonadism (LOH) and androgens: Validity of the measurement of free testosterone levels in the diagnostic criteria in Japan. Int. J. Urol. 2009;16:168&#x2013;174. doi: 10.1111/j.1442-2042.2008.02203.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2042.2008.02203.x</ArticleId><ArticleId IdType="pubmed">19054164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software &#x2018;EZR&#x2019; for medical statistics. Bone Marrow Transplant. 2013;48:452&#x2013;458. doi: 10.1038/bmt.2012.244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId><ArticleId IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F.C., Tajar A., Beynon J.M., Pye S.R., Silman A.J., Finn J.D., O&#x2019;Neill T.W., Bartfai G., Casanueva F.F., Forti G., et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N. Engl. J. Med. 2010;363:123&#x2013;135. doi: 10.1056/NEJMoa0911101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0911101</ArticleId><ArticleId IdType="pubmed">20554979</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieschlag E. Late-onset hypogonadism: A concept comes of age. Andrology. 2020;8:1506&#x2013;1511. doi: 10.1111/andr.12719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12719</ArticleId><ArticleId IdType="pubmed">31639279</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada K., Hanayama Y., Yasuda M., Hasegawa K., Obika M., Kataoka H., Itoshima K., Okada K., Otsuka F. Clinical relevance of low androgen to gastroesophageal reflux symptoms. Endocr. J. 2018;65:1039&#x2013;1047. doi: 10.1507/endocrj.EJ18-0187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ18-0187</ArticleId><ArticleId IdType="pubmed">30068893</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone R.W. More Than Just Heartburn: Does Famotidine Effectively Treat Patients with COVID-19? Dig. Dis. Sci. 2021;66:3672&#x2013;3673. doi: 10.1007/s10620-021-06875-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-021-06875-w</ArticleId><ArticleId IdType="pmc">PMC7903029</ArticleId><ArticleId IdType="pubmed">33625612</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G., Cai Y., Yi X., Li Y., Lin Y., Li Q., Xu J., Ke M., Xue K. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study. J. Med. Virol. 2020;92:2124&#x2013;2129. doi: 10.1002/jmv.25998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25998</ArticleId><ArticleId IdType="pmc">PMC7272861</ArticleId><ArticleId IdType="pubmed">32396239</ArticleId></ArticleIdList></Reference><Reference><Citation>Apaydin T., Sahin B., Dashdamirova S., Dincer Yazan C., Elbasan O., Ilgin C., Bilgin H., Cam H.K., Bahramzada G., Kucuk A., et al. The association of free testosterone levels with coronavirus disease 2019. Andrology. 2022 doi: 10.1111/andr.13152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.13152</ArticleId><ArticleId IdType="pubmed">34994082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadihasanoglu M., Aktas S., Yardimci E., Aral H., Kadioglu A. SARS-CoV-2 Pneumonia Affects Male Reproductive Hormone Levels: A Prospective, Cohort Study. J. Sex Med. 2021;18:256&#x2013;264. doi: 10.1016/j.jsxm.2020.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsxm.2020.11.007</ArticleId><ArticleId IdType="pmc">PMC7691132</ArticleId><ArticleId IdType="pubmed">33468445</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A., Pontillo M., Capogrosso P., Gregori S., Tassara M., Boeri L., Carenzi C., Abbate C., Cignoli D., Ferrara A.M., et al. Severely low testosterone in males with COVID-19: A case-control study. Andrology. 2021;9:1043&#x2013;1052. doi: 10.1111/andr.12993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12993</ArticleId><ArticleId IdType="pmc">PMC8013327</ArticleId><ArticleId IdType="pubmed">33635589</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.T., Hulme J., Tran H.D., Vo T.K., Vo G.V. The potential impact of COVID-19 on male reproductive health. J. Endocrinol. Investig. 2022:1&#x2013;13. doi: 10.1007/s40618-022-01764-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-022-01764-z</ArticleId><ArticleId IdType="pmc">PMC8856879</ArticleId><ArticleId IdType="pubmed">35181849</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastrelli G., Di Stasi V., Inglese F., Beccaria M., Garuti M., Di Costanzo D., Spreafico F., Greco G.F., Cervi G., Pecoriello A., et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology. 2021;9:88&#x2013;98. doi: 10.1111/andr.12821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12821</ArticleId><ArticleId IdType="pmc">PMC7280645</ArticleId><ArticleId IdType="pubmed">32436355</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta S., Sengupta P. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology. Reprod. Sci. 2021;28:23&#x2013;26. doi: 10.1007/s43032-020-00261-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43032-020-00261-z</ArticleId><ArticleId IdType="pmc">PMC7351544</ArticleId><ArticleId IdType="pubmed">32651900</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Guan C., Chen R., Wang Y., Feng S., Wang R., Qu G., Zhao S., Wang F., Wang X., et al. Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients. Cell Mol. Immunol. 2021;18:487&#x2013;489. doi: 10.1038/s41423-020-00604-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00604-5</ArticleId><ArticleId IdType="pmc">PMC7734388</ArticleId><ArticleId IdType="pubmed">33318629</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Ye Z., Zhang A.J., Chan J.F., Song W., Liu F., Chen Y., Kwan M.Y., Lee A.C., Zhao Y., et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters. Clin. Infect. Dis. 2022 doi: 10.1093/cid/ciac142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac142</ArticleId><ArticleId IdType="pmc">PMC8903466</ArticleId><ArticleId IdType="pubmed">35178548</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani A.S., Mukhtar N., Aljomaiah A., Aljamei H., Bakhsh A., Alsudani N., Elsayed T., Alrashidi N., Fadel R., Alqahtani E., et al. The Impact of COVID-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis. Endocr. Pract. 2021;27:83&#x2013;89. doi: 10.1016/j.eprac.2020.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7837186</ArticleId><ArticleId IdType="pubmed">33554871</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo B., Tan T., Clarke S.A., Mills E.G., Patel B., Modi M., Phylactou M., Eng P.C., Thurston L., Alexander E.C., et al. Thyroid Function before, during, and after COVID-19. J. Clin. Endocrinol. Metab. 2021;106:e803&#x2013;e811. doi: 10.1210/clinem/dgaa830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa830</ArticleId><ArticleId IdType="pmc">PMC7823247</ArticleId><ArticleId IdType="pubmed">33180932</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y.S., You J.H., Cha J.S., Park J.K. The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: A study in 1221 men. Aging Male. 2016;19:209&#x2013;214. doi: 10.1080/13685538.2016.1229764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13685538.2016.1229764</ArticleId><ArticleId IdType="pubmed">27750487</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada K., Hanayama Y., Obika M., Itoshima K., Okada K., Otsuka F. Involvement of serum dehydroepiandrosterone sulfate in erythropoietic activity. Aging Male. 2020;23:756&#x2013;763. doi: 10.1080/13685538.2019.1592151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13685538.2019.1592151</ArticleId><ArticleId IdType="pubmed">30905228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T., Yamada T. Association of bioavailable estradiol levels and testosterone levels with serum albumin levels in elderly men. Aging Male. 2008;11:63&#x2013;70. doi: 10.1080/13685530701779234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13685530701779234</ArticleId><ArticleId IdType="pubmed">18570057</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A., Corona G., Giwercman A., Maggi M., Minhas S., Nappi R.E., Sofikitis N., Vignozzi L. SARS-CoV-2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project. Andrology. 2021;9:19&#x2013;22. doi: 10.1111/andr.12811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12811</ArticleId><ArticleId IdType="pubmed">32369678</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Siso-Almirall A., Brito-Zeron P., Conangla Ferrin L., Kostov B., Moragas Moreno A., Mestres J., Sellares J., Galindo G., Morera R., Basora J., et al. Long COVID-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int. J. Environ. Res. Public Health. 2021;18:4350. doi: 10.3390/ijerph18084350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18084350</ArticleId><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>